Kangwon National University Hospital
Chuncheon, Gangwon-do, 24289, South Korea
NCT Number: NCT04646278
Study for developing techniques to evaluate coronary artery hemodynamic profiles by conventional angiography without more dedicated measuring devices.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Chuncheon, Gangwon-do, 24289, South Korea
A TIMI frame count is measured by counting the angiographic image cine frames during a head of radiocontrast column runs from the entry of left anterior descending artery (LAD) to the distal end.
A coronary clearance frame count is measured by counting the angiographic image cine frames during a tail of radiocontrast column runs from the entry of LAD to the distal end.
Baseline angiography is performed without any stimulation and hyperemic angiography is performed after intracoronary injection of adenosine 300ug or nicorandiol 2mg.
Inclusion criteria
Exclusion criteria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hyperemic simuli of coronary flow by adenosine or nicorandil injection
Other names: Hyperemia
Time frame: Imediately after the procedure
frame count between the beginning and end of contrast column head
Time frame: Imediately after the procedure
frame count between the beginning and end of contrast column tail
Time frame: During the procedure
derived from distal coronary pressure by transit time
Time frame: During the procedure
measured by pressure wire
Time frame: During the procedure
measured by pressure wire by thermodilution technique
KangWon National University Hospital
Other
Estimation of Coronary Artery Hemodynamic Profiles Using Cineangiography Technique
Acronym: ESCARGOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details